Pulling Out All the Stops to Sell More COVID Shots
This year, Pfizer, Inc. and Moderna, Inc. have experienced sharply declining sales of their messenger RNA (mRNA) COVID-19 shots, Comirnaty and Spikevax. Pfizer reported first-quarter (ending Mar. 31, 2023) sales of $3 billion for Comirnaty—down 75 percent from the same period in 2022. It posted second-quarter (ending June 30) sales of $1.49 billion—down 83 percent […]
These Endless Coronavirus Mutations
Shortly after the global campaign to control infection with the SARS-CoV-2 virus using mRNA COVID-19 shots began in the United States on Dec. 14, 2020, one of the concerns expressed by some scientists and doctors was that mass use of the bioengineered products might cause the virus to mutate and lead to variants and subvariants, […]
Annual COVID Shot. Is it Inevitable?
In a recent interview, the newly appointed director of the U.S. Centers for Disease Control and Prevention (CDC) suggested that the agency may soon come out with a recommendation for Americans to be vaccinated for COVID-19 every year.1 2 Mandy Cohen, MD, MPH, who was sworn in as the 20th CDC director on July 10, […]
Officials at Federal Gov’t Agencies, White House Sued for Censoring COVID Information
Sixty-seven U.S. federal government agencies and officials, including senior officials in the White House, have been accused of engaging in a widespread campaign of pressuring and colluding with social media platforms to censor users in violation of the First Amendment of the U.S. Constitution. Former Missouri Attorney General, Eric Schmitt and Louisiana Attorney General, Jeff […]
CDC Gives More Than $3 Billion to Local and State Health Departments
Officials at the U.S. Centers for Disease Control and Prevention (CDC) announced that they are distributing $3.2 billion to state, local, and territorial health departments across the United States in what they describe as an attempt to “strengthen” public health initiatives. CDC director Rochelle Walensky, MD said the money will give local agencies critical funding […]
Monoclonal Antibodies No Longer Effective Against New Strains of SARS-CoV-2
Monoclonal antibodies, which are synthetic versions of antibodies that are produced in a lab, appear to have lost effectiveness against COVID-19 disease as new variants of the virus emerge. Previously touted as the top-of-the-line outpatient treatment by public health officials and many clinicians, monoclonal antibodies have fallen out of favor as outpatient treatment for patients […]
